Hand, Foot And Mouth Disease - Pipeline Review, H2 2015
Summary
Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H2 2015’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hand, Foot And Mouth Disease and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global therapeutic landscape of Hand, Foot And Mouth Disease
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Hand, Foot And Mouth Disease and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Hand, Foot And Mouth Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Hand, Foot And Mouth Disease pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Hand, Foot And Mouth Disease
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Hand, Foot And Mouth Disease pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hand, Foot And Mouth Disease Overview 6
Therapeutics Development 7
Pipeline Products for Hand, Foot And Mouth Disease - Overview 7
Pipeline Products for Hand, Foot And Mouth Disease - Comparative Analysis 8
Hand, Foot And Mouth Disease - Therapeutics under Development by Companies 9
Hand, Foot And Mouth Disease - Therapeutics under Investigation by Universities/Institutes 10
Hand, Foot And Mouth Disease - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Hand, Foot And Mouth Disease - Products under Development by Companies 14
Hand, Foot And Mouth Disease - Products under Investigation by Universities/Institutes 15
Hand, Foot And Mouth Disease - Companies Involved in Therapeutics Development 16
Chongqing Zhifei Biological Products Co., Ltd. 16
CJ CheilJedang Corp. 17
iQur Limited 18
Sentinext Therapeutics Sdn Bhd 19
Sinovac Biotech Ltd. 20
Takeda Pharmaceutical Company Limited 21
Hand, Foot And Mouth Disease - Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 25
Drug Profiles 27
CJ-40010 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
coxsackievirus [serotype A16] + enterovirus [serotype 71] vaccine - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
D-5 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
enterovirus [serotype 71] vaccine - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
foot and mouth disease virus like particle vaccine - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
hand foot and mouth disease vaccine - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
hand, foot and mouth (bivalent) viral like particle vaccine - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
TAK-021 - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Hand, Foot And Mouth Disease - Recent Pipeline Updates 36
Hand, Foot And Mouth Disease - Product Development Milestones 40
Featured News & Press Releases 40
May 14, 2015: Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities 40
Apr 24, 2014: Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project 40
Feb 26, 2014: Sinovac's EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine 41
May 30, 2013: Sinovac Files New Drug Application For EV71 Vaccine And Receives Filing Acceptance From Beijing Drug Administration 42
Apr 18, 2013: Sinovac Announces Presentation Of EV71 Vaccine Phase III Top-Line Results At 13th Annual World Vaccine Congress & Expo 42
Mar 14, 2013: Sinovac Reports Positive Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease 43
Jun 25, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial And Commercialization Preparation Status 44
Jun 11, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial 44
Mar 29, 2012: Sinovac Announces Publication Of Phase I Clinical Data Of EV71 Vaccine For Prevention Of Hand, Foot And Mouth Disease In Journal Vaccine 45
Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease 46
Appendix 47
Methodology 47
Coverage 47
Secondary Research 47
Primary Research 47
Expert Panel Validation 47
Contact Us 47
Disclaimer 48
List Of Tables
Number of Products under Development for Hand, Foot And Mouth Disease, H2 2015 7
Number of Products under Development for Hand, Foot And Mouth Disease - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Late Stage Development, H2 2015 11
Comparative Analysis by Clinical Stage Development, H2 2015 12
Comparative Analysis by Early Stage Development, H2 2015 13
Products under Development by Companies, H2 2015 14
Products under Investigation by Universities/Institutes, H2 2015 15
Hand, Foot And Mouth Disease - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H2 2015 16
Hand, Foot And Mouth Disease - Pipeline by CJ CheilJedang Corp., H2 2015 17
Hand, Foot And Mouth Disease - Pipeline by iQur Limited, H2 2015 18
Hand, Foot And Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H2 2015 19
Hand, Foot And Mouth Disease - Pipeline by Sinovac Biotech Ltd., H2 2015 20
Hand, Foot And Mouth Disease - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015 21
Assessment by Monotherapy Products, H2 2015 22
Assessment by Combination Products, H2 2015 23
Number of Products by Stage and Route of Administration, H2 2015 24
Number of Products by Stage and Molecule Type, H2 2015 26
Hand, Foot And Mouth Disease Therapeutics - Recent Pipeline Updates, H2 2015 36
List Of Figures
Number of Products under Development for Hand, Foot And Mouth Disease, H2 2015 7
Number of Products under Development for Hand, Foot And Mouth Disease - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Comparative Analysis by Early Stage Products, H2 2015 13
Assessment by Monotherapy Products, H2 2015 22
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 24
Number of Products by Top 10 Molecule Types, H2 2015 25
Number of Products by Stage and Top 10 Molecule Types, H2 2015 25
